Fig. 1From: A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDSa, b The Kaplan-Meier curve of patients from the training cohort; c, d The Kaplan-Meier curve of patients from the validation cohort. a, c The Kaplan-Meier curves of patients in different IPSS-R risk stratifications. b, d The Kaplan-Meier curves of patients in different mutation risk stratificationsBack to article page